Mankind Pharma consolidated net profit declines 21.72% in the September 2025 quarter
(06 Nov 2025)

Back
Net profit of Mankind Pharma declined 21.72% to Rs 511.51 crore in the quarter ended September 2025 as against Rs 653.47 crore during the previous quarter ended September 2024. Sales rose 20.77% to Rs 3697.16 crore in the quarter ended September 2025 as against Rs 3061.43 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales3697.163061.43 21
OPM %24.9227.67 -
PBDT845.84951.72 -11
PBT624.02851.23 -27
NP511.51653.47 -22

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew